Primary Site >> Liver Cancer

Gene >> KLB

  • 2012
  • 2014
  • 2015
  • 2017
  • 2018
Ref: Klotho-beta overexpression as a novel target for suppressing proliferation and fibroblast growth factor receptor-4 signaling in hepatocellular carcinoma.
PMID: 22439738
Ref: Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19.
PMID: 24728076
Ref: First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway.
PMID: 25776529
Ref: Paralog-Specific Kinase Inhibition of FGFR4: Adding to the Arsenal of Anti-FGFR Agents.
PMID: 25847957
Ref: Fibroblast Growth Factor 15/19 in Hepatocarcinogenesis.
PMID: 28249259
Ref: Multiplexed gene expression profiling identifies the FGFR4 pathway as a novel biomarker in intrahepatic cholangiocarcinoma.
PMID: 28445152
Ref: Downregulation of klotho beta is associated with invasive ductal carcinoma progression.
PMID: 29344186
Ref: Bile Acid Sequestration by Cholestyramine Mitigates FGFR4 Inhibition-Induced ALT Elevation.
PMID: 29432567